Axon Enterprise (AXON) has been in focus after reporting Q1 2026 results, alongside a lift to its full year revenue growth outlook to 30% to 32%, citing stronger AI driven and international demand.

Despite the strong Q1 update and higher growth outlook, Axon Enterprise’s recent share price tells a mixed story, with a 1-month share price return of 13.79% but a year to date share price decline of 30.13%, while the 5-year total shareholder return of 218.93% shows how far the stock has come over a longer horizon.

If Axon’s AI push has your attention, it could be a good time to see what else is happening in this space via our screener of 60 profitable AI stocks that aren't just burning cash

So with Axon lifting its 2026 growth outlook, the stock still down sharply this year and trading well below many analyst targets, is this weakness giving you a genuine entry point, or is the market already looking through to that future growth?

Most Popular Narrative: 35.1% Undervalued

Axon Enterprise’s most followed narrative pegs fair value at $606.83, well above the last close at $393.66, which frames the recent share price weakness very differently.

One company I find particularly interesting is Axon Enterprise. Many investors still associate the company primarily with TASER devices, but I think the more compelling part of the story is how Axon has quietly transformed itself into a software and data platform for public safety. What began as a hardware business is increasingly becoming an ecosystem built around digital evidence, cloud software, and connected policing tools.

According to AryaWinningSon, this valuation leans heavily on Axon’s shift toward recurring software revenue, higher margin cloud services, and a profit multiple usually reserved for established platform leaders. To see which specific growth, margin, and valuation assumptions sit behind that $606.83 number and how they translate into the implied upside, the full narrative lays those out in detail.

Result: Fair Value of $606.83 (UNDERVALUED)

However, the story can change quickly if Axon’s software adoption slows or if public safety budgets tighten, putting pressure on its recurring revenue expectations.

Another View: DCF Paints a Much Tighter Picture

The community fair value of $606.83 suggests Axon Enterprise looks undervalued, but our DCF model reaches a very different conclusion. On this view, Axon’s last close of $393.66 sits slightly above an estimated future cash flow value of $390.06, which points to a stock that is closer to fully priced than discounted.

When one method implies meaningful upside and another signals only a small premium, it raises a practical question for you as an investor: which set of assumptions about Axon’s future cash generation feels more realistic?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Axon Enterprise for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 44 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With such mixed signals around value, growth, and sentiment, now is the time to review the data yourself and decide where you stand using the 1 key reward and 3 important warning signs.

Looking for more investment ideas?

If you want to keep sharpening your watchlist, now is the moment to scan other opportunities and avoid missing stocks that better match your style.

• Target potential upside with companies that combine quality with attractive pricing by checking out the 44 high quality undervalued stocks.
• Strengthen the defensive side of your portfolio by focusing on companies with robust finances using the solid balance sheet and fundamentals stocks screener (46 results).
• Get ahead of the crowd by reviewing a screener containing 22 high quality undiscovered gems before they land on everyone else's radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.